Has Jeffrey Weinberg received payments from drug or device companies?

Yes. Drug and device makers reported $7,019 in general payments to Jeffrey Weinberg across 107 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Weinberg did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Weinberg come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Weinberg

Physical Medicine & Rehabilitation · Staten Island, NYNPI 1952385361

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,880 of the $7,019 with a category attached, or 69.5%. 12 manufacturers reported payments, led by Fresenius Kabi USA, LLC at 41.8% of the total. Reporting peaked in 2023 at $3,266 and has fallen 90.3% since, to $318 in 2025. Among physical medicine & rehabilitation clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,019in general payments, 2019–2025

Across 107 payments — averaging $65.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Fresenius Kabi USA, LLC$3K
UCB, Inc.$2K
Dermavant Sciences, Inc.$566
Incyte Corporation$397
Novartis$388
Sun Pharmaceutical Industries Inc.$170
plus $401 from 6 others

$78,251in research payments, 2019–2025

Across 4 payments — averaging $19,563 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$78K

What the payments were for

Consulting fees$4,88070%
Food & beverage$2,13930%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Fresenius Kabi USA, LLC	2	$2,934
UCB, Inc.	3	$2,162
Dermavant Sciences, Inc.	47	$566
Incyte Corporation	18	$397
Novartis	23	$388
Sun Pharmaceutical Industries Inc.	5	$170
AbbVie	1	$145
LEO Pharma Inc.	1	$109
Pfizer	1	$53
E.r. Squibb & Sons, L.L.C.	2	$39
Organon	3	$37
Merz North America, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Idacio$2,750
Skyrizi$145
ADBRY$109
ILUMYA$102

How this compares

$7,019 in reported general payments places this provider in the 90th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York →

Other physical medicine & rehabilitation in Staten Island

Christopher PerezStaten Island$9K
Adolph MeyerStaten Island$8K
Heidi FuscoNew York$153K
Geraldine DapulRochester$77K
Michael OdellNew York$67K
Craig AntellNew York$65K
Michael StubblefieldNew York$53K
Heakyung KimNew York$53K
Jeffrey BazarianRochester$47K
Martin SchaefferLiverpool$41K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →